Effects of lipoprotein apheresis on PCSK9 levels.
Julius U, Milton M, Stoellner D, Rader D, Gordon B, Polk D, Waldmann E, Parhofer KG, Moriarty PM.
Julius U, et al. Among authors: waldmann e.
Atheroscler Suppl. 2015 May;18:180-6. doi: 10.1016/j.atherosclerosissup.2015.02.028.
Atheroscler Suppl. 2015.
PMID: 25936324